- Home
- FFWM vs SLDB Comparison
FFWM vs SLDB Comparison
Compare FFWM & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFWM
- SLDB
- Stock Information
- Founded
- FFWM 1990
- SLDB 2013
- Country
- FFWM United States
- SLDB United States
- Employees
- FFWM N/A
- SLDB N/A
- Industry
- FFWM Major Banks
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FFWM Finance
- SLDB Health Care
- Exchange
- FFWM Nasdaq
- SLDB Nasdaq
- Market Cap
- FFWM 409.3M
- SLDB 366.2M
- IPO Year
- FFWM 2014
- SLDB 2018
- Fundamental
- Price
- FFWM $5.21
- SLDB $3.45
- Analyst Decision
- FFWM Buy
- SLDB Strong Buy
- Analyst Count
- FFWM 4
- SLDB 10
- Target Price
- FFWM $6.75
- SLDB $18.10
- AVG Volume (30 Days)
- FFWM 653.3K
- SLDB 1.2M
- Earning Date
- FFWM 04-24-2025
- SLDB 03-06-2025
- Dividend Yield
- FFWM 0.19%
- SLDB N/A
- EPS Growth
- FFWM N/A
- SLDB N/A
- EPS
- FFWM N/A
- SLDB N/A
- Revenue
- FFWM $96,072,000.00
- SLDB N/A
- Revenue This Year
- FFWM $197.21
- SLDB N/A
- Revenue Next Year
- FFWM $11.52
- SLDB $717.65
- P/E Ratio
- FFWM N/A
- SLDB N/A
- Revenue Growth
- FFWM N/A
- SLDB N/A
- 52 Week Low
- FFWM $4.52
- SLDB $2.88
- 52 Week High
- FFWM $8.52
- SLDB $12.95
- Technical
- Relative Strength Index (RSI)
- FFWM 58.36
- SLDB 32.52
- Support Level
- FFWM $4.80
- SLDB $4.12
- Resistance Level
- FFWM $5.33
- SLDB $4.44
- Average True Range (ATR)
- FFWM 0.19
- SLDB 0.37
- MACD
- FFWM 0.07
- SLDB -0.20
- Stochastic Oscillator
- FFWM 81.82
- SLDB 0.87
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.